Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03326089
What this trial is testing

Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Corfu General Hospital 20
Early research (Phase 1)Study completedNCT07225296
What this trial is testing

A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genosco Inc. 63
Not applicableLooking for participantsNCT06323876
What this trial is testing

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Virginia 160
Early research (Phase 1)Study completedNCT02478268
What this trial is testing

Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Bastiaan Driehuys 64
Not applicableStudy completedNCT02551068
What this trial is testing

High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of British Columbia 78
Testing effectiveness (Phase 2)Study completedNCT06335303
What this trial is testing

Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 322
Early research (Phase 1)Active Not RecruitingNCT05515627
What this trial is testing

Atezolizumab for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical Center 24
Very early researchLooking for participantsNCT06853145
What this trial is testing

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Virginia 6
Not applicableLooking for participantsNCT03297775
What this trial is testing

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
University of Colorado, Denver 750
Not applicableLooking for participantsNCT06756230
What this trial is testing

Downhill Walking in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Saglik Bilimleri Universitesi 34
Large-scale testing (Phase 3)Ended earlyNCT01777737
What this trial is testing

Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole

Who this might be right for
Idiopathic Pulmonary Fibrosis
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 3
Not applicableStudy completedNCT02818712
What this trial is testing

Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up

Who this might be right for
Idiopathic Pulmonary Fibrosis
Aarhus University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Testing effectiveness (Phase 2)Study completedNCT04396756
What this trial is testing

Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT04533022
What this trial is testing

Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Vicore Pharma AB 52
Not applicableUnknownNCT03560154
What this trial is testing

Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Pulmonary Fibrosis
Istanbul University 60
Large-scale testing (Phase 3)Looking for participantsNCT06125327
What this trial is testing

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 210
Testing effectiveness (Phase 2)Study completedNCT02846324
What this trial is testing

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Global Blood Therapeutics 39
Post-approval studies (Phase 4)Study completedNCT02579603
What this trial is testing

Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 105
Early research (Phase 1)UnknownNCT06482190
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary FibrosisLung; Disease, Interstitial, With Fibrosis
Shenzhen Resproly Biopharmaceutical Co., Ltd 72
Next Page